[Page Banner Image]

The following is a review of diagnostics related medical research worldwide

The information is updated the first week of every month - so ... make this a regular stop in your information gathering activities.

The following information has been compiled from publicly available sources, StratCom does not assume any responsibility for the accuracy or the authenticity of the information and StratCom cannot be held liable for errors.

[HRule Image]

Research News for October 2003

Researchers at the Royal Victoria Hospital, Montreal, QC and members of the Insulin Resistance Atherosclerosis Study have found that apolipoprotein B (apoB) appears to represent a better index of cardiac disease risk than does low-density lipoprotein cholesterol (LDLC) level. The study showed that patients who had a high triglyceride level and a high apoB were the ones more likely to have high blood sugar, more insulin resistance, more inflammation, and more prothrombogenic factors. The group suggests two choices for assessing patients at risk. 1) Include apoB as part of a routine panel, 2) run apoB when patients present with high triglyceride levels or a low HDL.
Source: Circulation: Journal of the American Heart Association, November 11, 2003

Scientists at the Weill Cornell School of Medicine, New York, have discovered a potential new marker to diagnose acute cardiac events in the ER. Myeloperoxidase (MPO) is made in white blood cells and produced when arteries are inflamed and have rupture-prone fatty deposits. The researchers suggest that MPO testing can detect the early stages of a heart attack. Further it could be used with other tests such as hsCRP as a marker of inflammation and cardiac disease risk. The study used the OXIS-MPO Oxidative Stress assay from Oxis International. Inc.

Recent guidelines released by the American Thoracic Society and the European Respiratory Society advise that all adults diagnosed with chronic obstructive pulmonary disease (COPD), emphysema, adult-onset asthma, or unexplained liver disease should undergo genetic testing for alpha-1 antitrypsin deficiency. The rational for this is that alpha-1 antitrypsin deficiency can masquerade as COPD or asthma. The test allows clinicians to prescribe enzyme replacement therapy in addition to those required for COPD management.
Source: American Journal of Respiratory and Critical Care Medicine, October 1, 2003.

[HRule Image]

* Research News - September 2003
* Research News - Summer 2003
* Research News - May 2003
* Research News - April 2003
* Research News - March 2003
* Research News - February 2003
* Research News - January 2003
* Research News - December 2002
* Research News - November 2002
* Research News - October 2002
* Research News - September 2002
* Research News - Summer 2002
* Research News - June 2002
* Research News - May 2002
* Research News - April 2002
* Research News - March 2002
* Research News - February 2002
* Research News - January 2002
* Research News - December 2001
* Research News - November 2001
* Research News - October 2001
* Research News - September 2001
* Research News - Summer 2001
* Research News - May 2001
* Research News - April 2001
* Research News - March 2001
* Research News - February 2001
* Research News - January 2001
* Research News - December 2000
* Research News - November 2000
* Research News - October 2000
* Research News - September 2000
* Research News - July - August 2000
* Research News - June 2000
* Research News - May 2000
* Research News - April 2000
* Research News - March 2000
* Research News - Febuary 2000
* Research News - January 2000
* Research News - December 1999
* Research News - November 1999
* Research News - October 1999
* Research News - September 1999
* Research News - August 1999
* Research News - July 1999
* Research News - June 1999
* Research News - May 1999
* Research News - April 1999
* Research News - March 1999
* Research News - Fabuary 1999
* Research News - January 1999
* Research News - December 1998
* Research News - November 1998
* Research News - October 1998
* Research News - September 1998
* Research News - August 1998
* Research News - July 1998
* Research News - June 1998
* Research News - May 1998
* Research News - April 1998
* Research News - March 1998
* Research News - February 1998
* Research News - January 1998
* Research News - July 1997
* Research News - June 1997
* Research News - May 1997
* Research News - April 1997
* Research News - March 1997
* Research News - February 1997
* Research News - January 1997
* Research News - December 1996
* Research News - November 1996
* Research News - October 1996
* Research News - September 1996
* Research News - August 1996
* Research News - July 1996
* Research News - June 1996

[HRule Image]

Home | Company Profile | Services | Research Reports Available
Product Developments Worldwide | Research News | Health Care in Canada
Information Technology and Healthcare | Molecular Biology | Links

[HRule Image]
Send mail to stratcom@pagebleu.com with questions or comments about this web site.

Concept and Design Blue Page Productions
Copyright 1996-2003 STRATCOM

Last modified: November 3, 2003